Assessment of triglyceride glucose index in patients with non alcoholic fatty liver disease & its correlation with the disease severity. - NI

Tushar Akare0 个研究点目标入组 105 人开始时间: 待定最近更新: 2024年8月19日

试验速览

暂无简介。

•Evidence of fatty liver on ultrasonography of abdomen.
•Patients who satisfy the European Association for the Study of the Liver Criteria (EASL criteria) for NAFLD will be recruited for the study.
•EASL criteria for NAFLD is alcohol consumption less than 30 g/day for men and less than 20 g/day for women.
•Age >18 years and <65 years of any gender.

•Subjects having significant alcohol consumption (more than 30 gm/day in case of males and more than 20 gm/day in case of females)
•Pregnant or lactating women
•Subjects carrying hepatitis B and/or hepatitis C virus infection
•Patients with autoimmune hepatic disease
•Other chronic hepatic diseases i.e. Wilson’s disease, hereditary hemochromatosis, primary billiary cirrhosis etc.
•Patients on drugs that can lead to fatty liver e.g. methotrexate, amiodarone, anti- retroviral drugs, tamoxifene, barium salts, tetracycline, Estrogen, glucocorticoids, etc.
•Individuals having DM, metabolic syndrome, dyslipidemia and/or hypothyroidism
•Individuals having significant alcohol consumption and/or CLD
•Pregnant or lactating women.

发起方

Tushar Akare